摘要
心血管疾病(CVD)是终末期肾脏病(ESRD)血液透析患者的主要并发症。血液透析患者的心血管并发症可以分为两类:一类是心脏血管病变,常见如动脉粥样硬化;二是心肌病变,导致心脏本身结构和功能的改变,如心室肥厚和心脏扩张,而心力衰竭是这些过程的共同结果。由此可见,控制心力衰竭是提高血液透析质量和延长血液透析患者生存率的重中之重,文章从血液透析患者心力衰竭的危险因素、症状及防治方面的新进展做一简述。
Cardiovascular complication(CVD)is a major complication in hemodialysis patients with end-stage renal disease(ESRD). Vascular complications in hemodialysis patients can be divided into two categories: cardiac vascular disease,such as atherosclerosis and cardiomyopathy,which results in changes in the structure and function of the heart itself,such as ventricular hypertrophy,and cardiac dilatation,and heart failure is a common result of these processes. It can be concluded that the control of heart failure is the top priority to improve the quality of hemodialysis and prolong the life of hemodialysis patients. In this paper,the risk factors,symptoms and new progress in prevention and treatment of heart failure in hemodialysis patients are summarized.
作者
刘卫华
林紫宁
洪富源
LIU Wei-hua;LIN Zi-ning;HONG Fu-yuan(Provincial Clinical Medical College of Fujian Medical University,Department of Nephrology,Fujian Provinical Hospital,Fuzhou 350001,China)
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2021年第11期917-921,共5页
Chinese Journal of Practical Internal Medicine
基金
福建省自然科学基金(2019J01185)。
关键词
血液透析
心力衰竭
终末期肾脏病
hemodialysis
heart failure
end-stage renal disease
